Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A third Look: Discussing the potential of Roivant's batoclimab for normalizing of T3 and T4 hormone levels in patients with Graves’ disease

Ticker(s): IMVT, ROIV

Who's the expert?

Institution: Premier Endocrinology

Private practice endocrinologist at Premier Endocrinology.
Manages 100-200 patients with obesity and type 2 diabetes.

Interview Goal

On this call we will be discussing the initial results released in December from the ongoing 24-week Phase 2 for Batoclimab in Graves’ Disease with an endocrinologist.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.